New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A2200

Introduced
1/13/26  

Caption

Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

Impact

The introduction of A2200 is expected to improve health outcomes for pregnant individuals by facilitating better access to necessary monitoring tools. By obligating healthcare facilities and providers to equip patients with home blood pressure monitors and provide educational materials, the bill intends to empower patients to take an active role in their healthcare. Furthermore, the implications for state laws include ensuring that health insurance policies must adapt to include these measures, which may set a precedent for future maternal health legislation. The allocation of $1 million for reimbursement claims indicates a robust governmental commitment to enforcing these practices and tracking the health outcomes thereof, enhancing overall accountability.

Summary

Assembly Bill A2200 aims to enhance maternal health by focusing on the monitoring and management of preeclampsia, a serious condition that can arise during pregnancy. The bill mandates that health insurers provide coverage for self-measured blood pressure monitoring for pregnant individuals diagnosed with preeclampsia. It also requires healthcare providers to supply validated home blood pressure monitors to these patients at no cost, ensuring they are educated on their use. The legislation highlights the importance of early detection and ongoing monitoring of blood pressure to mitigate the risks associated with preeclampsia, which affects a significant percentage of pregnancies in New Jersey.

Contention

While A2200 presents significant potential benefits, discussions around the bill may highlight concerns related to funding and resource allocation. Some stakeholders may argue about the sustainability of the $1 million appropriation in meeting the expected demand for blood pressure monitors and the accompanying training. Additionally, there may be debates regarding the implementation logistics—how healthcare providers will be trained, how they will report outcomes to the Department of Health, and ensuring compliance across various healthcare settings. Critics may also raise questions about the effectiveness of the educational materials provided, emphasizing the need for comprehensive training that goes beyond pamphlets handed out during visits.

Companion Bills

NJ S2503

Carry Over Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

NJ A3562

Carry Over Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

NJ S3821

Same As Requires health insurers to cover self-measured blood pressure monitoring for subscribers with preeclampsia; requires health care professionals to provide home blood pressure monitor to pregnant patients diagnosed with preeclampsia.

Similar Bills

PA HR517

Recognizing the month of May 2026 as "Preeclampsia Awareness Month" in Pennsylvania.

NJ S299

Implements Blue Band Program to address preeclampsia in New Jersey.

NJ A2188

Establishes requirements to evaluate certain people who are pregnant and who have given birth for preeclampsia.

PA HR158

Designating the month of May 2025 as "Preeclampsia Awareness Month" in Pennsylvania.

NY J01943

Memorializing Governor Kathy Hochul to proclaim May 2026, as Preeclampsia Awareness Month in the State of New York

TN HB0070

AN ACT to amend Tennessee Code Annotated, Title 56; Title 63; Title 68 and Title 71, relative to coverage of biomarker testing for preeclampsia.

TN SB0205

AN ACT to amend Tennessee Code Annotated, Title 56; Title 63; Title 68 and Title 71, relative to coverage of biomarker testing for preeclampsia.

MS HB1025

Preeclampsia; Health Department prepare materials about complications of pregnancy due to, which providers shall provide to pregnant women.